Christopher Yea, CHIEF DEVELOPMENT OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 8,662 shares at $13.45 ($117K) on 2025-11-24, disclosed to the SEC on 2025-11-26.
Seasonal sale ($117k) by CHIEF DEVELOPMENT OFFICER — this insider has traded KALV in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.45 | 4,331 | $58K | 50.0% |
| 2 | $13.45 | 4,331 | $58K | 50.0% |
| Total | $13.45 avg | 8,662 | $117K | 100% |
| Filing → |
| KALV | SELL | 2026-05-26 | $63K | — | Filing → |
| KALV | SELL | 2026-05-19 | $30K | — | Filing → |
| KALV | SELL | 2026-02-24 | $68K | — | Filing → |